The emerging therapy of tirzepatide peptide represents a major advance in the management of the condition. Unlike existing drugs, tirzepatide affects multiple pathways – glucagon-like peptide-1 (GLP-1) and GIP – https://tirzepatidepeptide240646.yomoblog.com/49398462/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment